Crinetics Pharmaceuticals
CRNX
#3579
Rank
$2.84 B
Marketcap
$30.62
Share price
-8.71%
Change (1 day)
-34.19%
Change (1 year)

Operating Margin for Crinetics Pharmaceuticals (CRNX)

Operating Margin as of April 2025 (TTM): -28,720.70%

According to Crinetics Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is -28,720.70%. At the end of 2024 the company had an Operating Margin of -28,720.69%.

Operating Margin history for Crinetics Pharmaceuticals from 2022 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2024-28,720.69%437.25%
2023-5,345.85%54.49%
2022-3,460.38%-65.35%
2021-9,985.25%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
0.00%N/A๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.